You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 7, July 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Memory Impairment in Patients With Progressive Supranuclear Palsy

Irene Litvan, MD; Jordan Grafman, PhD; Claudia Gomez, MEd; Thomas N. Chase, MD

Arch Neurol. 1989;46(7):765-767.


Abstract

• Verbal memory was compared in 12 patients with progressive supranuclear palsy and 12 healthy control subjects matched for age, sex, and education. Learning, consolidation, and retrieval were significantly impaired in patients with progressive supranuclear palsy. Information scanning, which requires the use of short-term memory processes, remained intact. Duration of symptoms and degree of motor dysfunction correlated with intrusions during learning. No relation between central dopamine metabolism and memory dysfunction could be established.



Author Affiliations

From the Experimental Therapeutics Branch (Drs Litvan and Chase and Ms Gomez) and the Cognitive Neuroscience Unit, Medical Neurology Branch (Dr Grafman), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md.


Footnotes

Accepted for publication November 17, 1988.

Read in part at the 40th annual meeting of the American Academy of Neurology, Cincinnati, Ohio, April 1988.

Reprint requests to Experimental Therapeutics Branch, Bldg 10, Room 5C103, NINDS, National Institutes of Health, Bethesda, MD 20892 (Dr Chase).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk factors for progressive supranuclear palsy: a case-control study in France
Vidal et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:1271-1274.
ABSTRACT | FULL TEXT  

The contribution of the study of neurodegenerative disorders to the understanding of human memory
Panegyres
QJM 2004;97:555-567.
ABSTRACT | FULL TEXT  

Effects of Physostigmine on Spatial Attention in Patients With Progressive Supranuclear Palsy
Kertzman et al.
Arch Neurol 1990;47:1346-1350.
ABSTRACT  

Frontal Lobe Function in Progressive Supranuclear Palsy
Grafman et al.
Arch Neurol 1990;47:553-558.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.